SCYNEXIS, Inc. Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit
SCYNEXIS, Inc. (SCYX) had Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit of $0 as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit · last filed 2026-03-04
- 2025-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2024-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2023-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2022-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
| Period end | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-04 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-12 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-29 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-29 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-11 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-13 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-13 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-07 |
| 2014-12-31 | $0.00 8-K · filed 2015-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |